Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Biotechnology Startup Investors in Austria in November 2024

Last updated: Nov 2024 A list of 50 angel investors and VC (Venture Capital) funds that invest in Biotechnology startups based in Austria. We rank investors based on the number of investments they made in Biotechnology companies from Austria. We update this investor list every month.

Top 50 Biotechnology Startup Investors in Austria in November 2024

Investor	Biotechnology Austria investments
xista science ventures	10
xista science ventures	9
tecnet equity	6
SOSV	5
austria Wirtschaftsservice (aws)	5
MIG Capital	5
Schnidar Harald	3
Arax Capital Partners	3
BackBone Ventures	2
bmp Ventures	2
aws Gründungsfonds	2
TSVC	2
PUSH VC	2
Longevitytech.fund	2
Aescap Venture	2
R42 Group	2
red-stars.com	2
Nina Capital	2
Lansdowne Partners	2
Übermorgen Ventures	2
APEX Ventures	2
Matthias Wilrich	1
OrbiMed	1
HCVC	1
Clima Now	1
Synthesis Capital	1
Simon Capital	1
NovaCapital	1
Satgana	1
Forbion Capital Partners	1
Sofinnova Partners	1
SFG Steirische Wirtschaftsförderungsgesellschaft m.b.H	1
Polaris Partners	1
42CAP	1
PONTIS Venture Partners Management	1
Wellcome Trust	1
IPO Beteiligungs-Management	1
4SC	1
Gamma Capital Partners	1
Techno Venture Management	1
MCI Capital SA	1
HBM Partners	1
Tet Ventures	1
Valnon Holding	1
GLS Ventures	1
Die Wirtschaftskammer	1
10x Founders	1
Air Street Capital	1
Amino Collective	1
RKP InnoInvest	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Investment focus

Biotechnology, Medical, Medical Device
Seed, Pre-Seed, Series A
Austria, France, Slovenia

Portfolio highlights

Syntropic — Syntropic is a medical device company that develops novel technologies that helps for the treatment of psychiatric diseases and the improvement of cognitive abilities.
G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
HEPHAISTOS-Pharma — Hephaistos Pharma is a developing weapons firm. They provide services for oncology, immunotherapy, and cancer. An online inquiry form is available on the company's website.

Investment focus

Biotechnology, Medical, Software
Seed, Pre-Seed, Series A
Austria, Slovenia

Portfolio highlights

subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
VALANX Biotech — Protein conjugation. Specific, fast and cost effective.

tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.

Investment focus

Software, SaaS, Information Technology
Seed, Funding Round, Series A
Austria

Portfolio highlights

Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
Orderlion — Orderlion is aiming to become the gold standard for online ordering of restaurants & hotels from all their suppliers. Orderlion is already available in more than 20 cities in Austria, Germany, the Czech Republic, Switzerland and France with over 1.000 restaurants and hundreds of suppliers.Orderlion was designed for all types of hospitalitybusinesses (café, restaurant, hotel, chain). The order platform combines all suppliers and products in one app and enables customer-specific pricing. With little effort, the entire inventory of restaurants can be recorded and activated for automatic ordering processes. Orderlion counts numerous prominent restaurants among its customers. Orderlion was founded by Stefan Strohmer and Patrick Schubert in 2018 and has its headquarters in Vienna, Austria.
VALANX Biotech — Protein conjugation. Specific, fast and cost effective.

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Biotechnology, Health Care, Software
Seed, Convertible Note, Pre-Seed
United States, India, United Kingdom

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.

Investment focus

Software, Information Technology, Biotechnology
Seed, Grant, Pre-Seed
Austria, Belgium

Portfolio highlights

HD Immune — HD Immune develops an antibody to target the mutated protein and remove it from the body. HDI has a lead antibody mAB C6-17 which lowers mtHTT in the blood and organs.
Aitiologic — aitiologic is an Austrian precision medicine startup developing ai-powered solutions for early disease detection and targeted therapy.
revitalyze — Digital sales and cost-saving solutions for aggregates with a white label customer portal.

Zusammen gestalten wir die Unternehmen von morgen.

Investment focus

Biotechnology, Health Care, Medical
Series A, Funding Round, Series B
Germany, France, Austria

Portfolio highlights

Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
Innatera — Innatera is a Dutch nanotech company and an offspring of the Delft University of Technology in the Netherlands.

Entrepreneur, Angel Investor, Scientist and Inventor

Investment focus

mHealth, Software, Biopharma
Seed, Angel, Pre-Seed
Austria

Portfolio highlights

SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.

ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment

Investment focus

Biotechnology, Health Care, Medical
Seed, Funding Round
Austria

Portfolio highlights

AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
Calyxha Biotechnologies GmbH — A new perspective on inflammation

BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.

Investment focus

Information Technology, Artificial Intelligence, Software
Seed, Pre-Seed, Funding Round
Switzerland, Germany, Israel

Portfolio highlights

Evoralis — Utilise Our Innovative Enzymes to Efficiently Recycle Plastics Into High-Quality Raw Materials
Cloudsquid — is an an artificial intelligence based revenue orchestration company intended for companies with usage-based pricing models.
Exakt Health — Exakt Health is the physio app for sports injuries. The Exakt Health app guides users through self-diagnosis for frequent sports injuries and then creates an individualized rehabilitation plan.

bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.

Investment focus

Information Technology, Software, Manufacturing
Seed, Funding Round, Series A
Germany, United States, Austria

Portfolio highlights

Livil — Livil provides a toolkit for designing and delivering flexible employee benefits, including lifestyle, dental, and vision plans.
RAYDIAX — We are Raydiax.Interventional only.Our goal is to reinvent computer tomography that is focussed on treatment.
XenoPatch GmbH — First-ever portable device for pain management, seamlessly combines heat, cold and vibration treatment with an intuitive smartphone app.

aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.

Investment focus

Software, SaaS, Information Technology
Seed, Series A, Funding Round
Austria, United States, Germany

Portfolio highlights

Valutico — Valutico is the world‘s leading provider of web-based company valuation tools.Started in 2014 by a team of enthusiastic Corporate Finance professionals and web developers, the concept was born out of frustration with the status-quo in Corporate Finance practice: That professional company valuations used to be the domain of only the mostsophisticated of investors.At Valutico, it has been their mission from the outset to offer cutting-edge valuation tools to a much wider audience. Today they empower everybody to perform company valuations that meet and exceed the standards of even the leading investment banks and advisory firms.The company today is headquartered in Vienna/Austria and has an additional office in Frankfurt/Germany.
Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
Arkeon Biotechnologies — Arkeon turns CO2 into functional, carbon-negative ingredients for food

Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.

Investment focus

Software, Artificial Intelligence, Health Care
Seed, Funding Round, Series A
United States, China, Canada

Portfolio highlights

MyShell — The first AI consumer layer - build, share, and own AI Apps.
eBots — EBots is a collaborative robotics startup devoted to the development and manufacturing of intelligent robotics for industrial applications. They develop autonomous robotics designed for use in industrial applications and their platform combines machine learning with physical models, enabling users to realize intuitive human-machine interface,dexterous manipulation, and precise assembly. The company's platform combines machine learning with physical models, enabling users to realize an intuitive-human machine interface, dexterous manipulation, and precise assembly.EBots was founded in 2016 and is based in Fremont, CA, USA.
Ridge Security — Ridge Security is a computer and network services company that offers web app and server testing, and network infrastructure solutions.

| Investments that move industries

Investment focus

Software, Apps, Information Technology
Seed, Series A, Funding Round
Austria, Germany, United States

Portfolio highlights

Balun — Balun is a machine learning platform that forecasts electricity generation with unrivaled precision by analyzing multiple meteorological and energy market inputs, allowing renewable energy producers to optimize production, reduce penalties, and assure a stable, efficient grid.
enspired — enspired is a fully digital energy trading-as-a-service company. We drive the energy transition by enabling our clients to bring flexible assets to power spot markets and capture their full value with our AI-based trading services. Our team consists of leading algorithmic traders, data scientists and technology enthusiasts who firmly believe thatthe way power is traded will soon drastically change - in our world, there is no room for trading screens and traditional optimization. All trades get executed in a fully automated fashion using advanced AI algorithms that outperform the market and monetize our client's flexibility to the fullest while supporting grid stability. Our clients include leading utilities, operators of renewables and batteries or consumption assets across Europe.
FERNRIDE — Fernride enables automated, sustainable logistics by combining the skills of remote drivers with autonomous technologies.

Investing globally in technologies extending healthy lifespans

Investment focus

Biotechnology, Health Care, Personal Health
Seed, Convertible Note, Pre-Seed
United States, United Kingdom, The Netherlands

Portfolio highlights

Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
Rejuvenation Technologies — Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres. The company is headquartered in Mountain View, California.

The Aescap funds invest in highly innovative publicly traded biotech/life sciences companies. We're able to select the promising companies

Investment focus

Biotechnology, Pharmaceutical, Chemical
Series A, Series B, Funding Round
United Kingdom, Austria, Belgium

Portfolio highlights

Orphazyme — Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja JÃ¤Ã¤ttela and Thomas Kirkegaard Jensen from the Danish Cancer Society (KrÃ¦ftens BekÃ¦mpelse).Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
Avantium — Build a sustainable future with Avantium. Leading the change in green chemistry and innovative solutions.
F-Star Therapeutics — F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.

R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.

Investment focus

Biotechnology, Health Care, Information Technology
Seed, Funding Round, Pre-Seed
United Kingdom, United States, Austria

Portfolio highlights

Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.

red-stars.com is an operative holding company that invests in and manages companies that provide mission-critical products and offerings to enable DIGITALIZATION and LIFE SCIENCES.

Investment focus

Software, Biotechnology, Telecommunications
Funding Round, Seed
Austria, Germany

Portfolio highlights

Txture — Txture is an end-to-end cloud transformation platform for planning transformations, migration management and cloud infrastructure optimization.
a:head bio — a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids
HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Investment focus

Health Care, Artificial Intelligence, Software
Seed, Pre-Seed, Series A
United States, United Kingdom, Austria

Portfolio highlights

Noah Labs — Noah Labs is a compant that creates AI-powered software solutions for medical care and research that help diagnose, manage illnesses, and guide interventions.
Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
Lillian Care — Lillian is building a nationwide network of health facilities in Germany.

Fundamental Equity Investing, since 1998

Investment focus

Biotechnology, Machine Learning, Finance
Funding Round, Series A, Series B
United Kingdom, Austria, United States

Portfolio highlights

Nattergal — Nattergal is a company with a mission to deliver nature recovery at scale, to provide vital benefits for society and sustainable financial returns.
G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
Oxford Quantum Circuits — We deliver Enterprise ready quantum solutions that are hybrid workload ready

We are an early stage VC for climate tech startups.

Investment focus

Software, Energy, Renewable Energy
Seed, Pre-Seed, Funding Round
Germany, Switzerland, Finland

Portfolio highlights

Marathon Fusion — The fuel cycle for fusion energy.
Companion.energy — Software to manage industrial energy flexibility in the age of renewables.
Open Forest Protocol — With Open Forest Protocol (OFP), measure, report, verify and fund forestation projects with digital transparency

APEX Ventures is a deep-tech and medical-focused venture capital firm.

Investment focus

Artificial Intelligence, Health Care, Software
Seed, Series A, Funding Round
Germany, United Kingdom, Austria

Portfolio highlights

Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
CardiaTec Biosciences — CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery to deliver the next generation of therapeutics

Matthias Wilrich is the VP Vehicles and Supply Chain at TIER Mobility.

Investment focus

E-Commerce, Delivery Service, Mobile Apps
Seed, Pre-Seed, Series A
Germany, Austria, Malaysia

Portfolio highlights

Lumaly — Lumaly is a browser extension that automatically tries out and uses all available voucher codes in the cart when shopping online.
MAYD — MAYD provides telepharmacy platform providing healthcare-related goods in a convenient way by delivering it to doorstep.
HELLO INSIDE — HELLO INSIDE is a scientific self care company empowering people to have data-driven conversations with their bodies. Unlock your best self.

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, China, Israel

Portfolio highlights

Tyra Biosciences — Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Tyra is using its proprietary SNÅP platform, which is optimized to enable rapid and precise refinement of structural design through iterative molecular SNÅPshots, in orderto generate next-generation product candidates that are specifically designed to address acquired drug resistance and provide alternative treatment options. Tyra is initially focused on developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor, or FGFR, family, which are altered in approximately 7% of all cancers. Tyra’s lead product candidate, TYRA-300, is designed to selectively inhibit FGFR3, with an initial focus on patients with bladder cancer.
Forward Therapeutics — Forward Therapeutics idelivers blockbuster oral agents for chronic inflammatory conditions. Science that impacts patient care.
Odyssey Therapeutics — Odyssey Therapeutics is developing innovative medicines to make extraordinary leaps in outcomes for patients with cancer inflammatory diseases

HCVC is an early-stage Venture Capital firm backing hardtech companies worldwide. Beyond its fund, HCVC supports hardtech founders through Hardware Club, a selective global community of 500+ startups with dedicated resources, partnerships and events.

Investment focus

Software, Artificial Intelligence, Robotics
Seed, Series A, Pre-Seed
United States, France, United Kingdom

Portfolio highlights

Cowboy — Meet Cowboy, the connected electric bike for urban riders. With an intuitive motor to sense your pedaling force and a companion app in the cockpit to guide your ride, tune into a newfound freedom in the city.
atmio — atmio helps natural gas operations to find, fix and report methane emissions easily.
Surge — PreCyte integrates high-resolution immune system exploration with predictive information to develop preventive strategies, treatments, medical devices.

Wir wollen unser wichtigstes Erbe erhalten. Eine lebenswerte Erde.

Investment focus

Farming, Renewable Energy, Solar
Seed, Grant, Pre-Seed
Switzerland, Germany, Austria

Portfolio highlights

Voltiris — Voltiris filters natural sunlight to transmit it to plants and recycle the "wasted" sunlight into green electricity.
Planeteers — We capture CO2 in water and unleash the potential of the oceans as the largest carbon sink on our planet.
Infrascreen — The transparent aluminium screen for extra energy-savings in greenhouses. Thanks to it's low-e coating, it saves up to 20% more than a regular energy-saving screen

We are The Future Food Investors. Alternative Proteins Pioneers, we combine Smart Capital, Deep Expertise and Food Tech Startups!

Investment focus

Biotechnology, Food and Beverage, Organic Food
Seed, Funding Round, Series A
United States, Israel, Austria

Portfolio highlights

Triplebar — Triplebar provides sustainability, biotechnology, and synthetic biology research.
Savor — Savor makes delightfully rich foods without animals, farmland, fertilizers, hormones, or antibiotics.
Hyfé — Hyfé Foods is a biotech company producing ingredients by leveraging fungal fermentation to upcycle water byproducts from food manufacturers.

Simon Capital is an early-stage VC fund with €105M capital ready to invest in innovations that will improve our everyday lives, following the mission of investing “for the next generation”.

Investment focus

Software, Biotechnology, SaaS
Seed, Series A, Series B
Germany, Austria

Portfolio highlights

Infinite Roots — Mushlabs is a biotech company using fermentation to create the next generation of sustainable foods from the roots of mushrooms.
Neople — Every employee deserves an assistant. Meet the Neople, and increase your productivity simply by starting a conversation with them. Trained on your documents, available in your pocket.
Pacifico Biolabs — Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of sustainable and food alternatives.

NovaCapital invests in the union between entrepreneurs and innovation. It offers international and managerial experience, to transform innovative start-ups and already established companies into structured companies, with managerial skills and an international network.

Investment focus

Software, Artificial Intelligence, Information Technology
Seed, Pre-Seed, Series A
Italy, Austria

Portfolio highlights

ISAAC — ISAAC is an innovative tech company at the forefront of enhancing structural resilience through advanced active mass damper systems. Specializing in seismic and wind protection, ISAAC's solutions dynamically improve the stability of existing buildings and infrastructure. Utilizing non-invasive retrofitting techniques, our active mass dampersenhance the safety and comfort of structures under dynamic loads without altering their original aesthetics. This approach not only safeguards buildings during natural events but also contributes to greener construction practices by avoiding extensive reconstruction, aligning with sustainable development goals in urban environments.
Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
Newarc srl — With the help of technology, we simplify and improve the home buying and selling process.

Satgana is a Climate Tech VC firm on a mission to invest in planet-positive startups building the Future of Earth.

Investment focus

Electronics, B2B, Biotechnology
Pre-Seed, Seed
Kenya, France, Austria

Portfolio highlights

Estuaire — Estuaire It seeks to strengthen the aviation sector by lessening its negative environmental effects. Their data firm is investigating all aspects of aviation pollution, such as CO2 emissions, NOx emissions, contrails, and aircraft production. Actionable indicators are provided to airlines, lessors, and carbon calculators to lessen the impact of airtravel.
Brineworks — Brineworks is making sustainble CO2 and H2 production afforable. The building blocks for green fuels - from seawater.
Sirona Technologies — Pioneering direct air capture (DAC) technology with a focus on speed, scalability and a low capex design.

Impacting the future of medicine.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, United Kingdom, The Netherlands

Portfolio highlights

Aiolos Bio — Long Description: Aiolos Bio is a biotech company focused on developing therapies for respiratory diseases like asthma as well as other immune conditions. The company is initially focused on advancing AIO-001, a monoclonal antibody therapy for moderate-to-severe asthma that only requires dosing every 6 months. Aiolos Bio was founded by anaccomplished team with decades of drug development experience and leadership in the biotech industry.
Tessellate BIO — Tessellate BIO is redefining synthetic lethality in cancer beyond homologous recombination deficiency, turning cancer patients into cancer surivivors.
Rampart Bioscience — Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from avariety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

BetterOmics — The Omics AI Cloud
l`école — l'école AI is a computer vision-focused development platform. Its objective is to enable humans to use AI with purpose to change the future, beginning with a focus on speeding advances in life sciences using computer vision.
Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.

Financing for startups in Styria

Investment focus

Software, Audio, Travel
Seed, Grant, Funding Round
Austria

Portfolio highlights

teamazing — ONLINE TEAM EVENTS, BUT AMAZING! We enthuse teams. For better teamwork and more fun at work. This leads to better products, higher profitability and happier employees. teamazing was founded in 2014 as a startup in Graz. The winning team now counts 25 employees in Graz, Vienna and Munich and specialized in online team building during the Coronacrisis. Before that, the company expanded to Germany in 2018 and became the market leader for teambuilding events in Austria in 2019.
Busfinder.com — Reisebus mieten mit Fahrer. Bus Angebote von Busunternehmen vergleichen und online buchen. Jetzt Bus buchen auf busfinder.com
Delphi Data Labs — Unlock your hidden market potential and use your data to its fullest potential. We offer everything from market analysis, data modelling and vizualization to system integration in your existing technical environment to super-charge your decision-making.

Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, Singapore, Ireland

Portfolio highlights

Candesant Biomedical — Candesant Biomedical develops treatment for excessive sweating and hyperhidrosis. It offers a technology that is based on the principle that alkali metals in contact with water generate energy. The insight was that when the amounts of metal and water are controlled, the result is targeted delivery of energy exactly at the site of the water. Itsdevice is designed to target and inactivate the most active sweat glands.The company was founded in 2016 and is headquartered in San Francisco, California.
Larkspur Biosciences — Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.
Crossbow Therapeutics — Crossbow Therapeutics is a seed-stage, stealth-mode oncology startup company. The company develops antibody engineering for intracellular cancer targets.

We are peers amongst entrepreneurs helping the brave to build game-changing companies, just like we have done ourselves.

Investment focus

Software, SaaS, Artificial Intelligence
Seed, Series A, Series B
Germany, France, Sweden

Portfolio highlights

Codesphere — Codesphere is your Zeroconfig Cloud. No config - just code and run web apps from your browser. Team work on distributed full stack Typescript, and benefit from our automatic deployments, scaling, tests, and security / privacy audits. We optimize each and every detail to keep things simple for you. Codesphere is next level programming.
simplyblock — High-performance storage software designed for databases with low latency, high scalability and high IOPS. NVMe-optimized. Alternative SAN or EBS. Scalable Block Storage software. Simplyblock | Simply Block | Simplyblock Block Storage
Go Autonomous — Unlock advantages of Autonomous Commerce and experience heightened efficiency, reduced costs, and seamlessly interaction for both buyers and sellers.

PONTIS Capital manages two funds with total commitments of more than EUR 60 million, and is actively investing out of its second fund, PONTIS Growth Capital II (“PGC II”). The focus of PGC II is to invest in small and medium-sized growth companies with Established technology or other competitive advantage Existing proof-of-market in marketswith growth potential,Scalable business models, andHeadquarters in the DACH region (Germany, Austria, Switzerland)

Investment focus

Software, Manufacturing, Information Technology
Series A, Series B, Series C
Austria, Germany

Portfolio highlights

evidanza — evidanza GmbH is a software provider of business intelligence solutions for reporting, planification, OLAP-analysis, risk management, costs calculations, IFRS- and USGAAP-reporting. The company is headquartered in Salching, Germany.
SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.

Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Grant, Series C, Funding Round
United States, United Kingdom, Germany

Portfolio highlights

Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
DataDotOrg — data.org brings together philanthropy, technology, academia, and social impact organizations to build the field of data science for social impact.
Feinstein Institute for Medical Research — Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes ofbehavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.

IPO Beteiligungs-Management is a private equity company specialized in early stage venture investments.

Investment focus

Sensor, Medical, Wireless
Series B, Funding Round
Austria

Portfolio highlights

SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.

4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.

Investment focus

Health Care, Biotechnology
Seed
Austria

Portfolio highlights

Panoptes Pharma — Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria.The development of Panoptes´ clinical candidate PP-001 focuses on a new treatment for autoimmune uveitis, a disease whichis one of the major causes of blindness. As a second indication, adenoviral conjunctivitis will be pursued, a disease for which to date, no treatment is available. Due to its unique mode of action, PP-001 has therapeutic potential for additional inflammatory and viral indications.Panoptes has an experienced team of development experts with a proven track record of developing and commercializing innovative products. The team is developing a focused portfolio of high-performance small molecule products, with its lead clinical candidate PP-001 in preclinical development.

GCP Gamma Capital Partners is a private Venture Capital investment and Equity consulting firm established in 2002 (GCP Presentation 2020). We focus on dynamic technology and growth companies in Austria, Germany, Switzerland and CEE countries bordering Austria. We aim for value creation and value realization to generate superior returns for our investors and clients.

Investment focus

Mobile, iOS, Mobile Apps
Series A, Seed, Series C
Austria, Switzerland, United States

Portfolio highlights

Wikitude — Wikitude Augmented Reality empowers your iOS, Android & Smart Glasses apps with Image & Object Tracking, Instant tracking (SLAM), Geo AR, and more.
42matters AG — 42matters offers a full suite of mobile and connected TV app intelligence solutions, including APIs, file dumps, and visual, web-based platforms.
Organica Water — Organica Water is a global provider of innovative solutions for the treatment and recycling of wastewater. Over the past two decades Organica has developed a truly unique approach, enabling customers all over the world to build and operate space and energy efficient biological wastewater treatment plants (WWTPs) that blend harmoniously into urbanand residential population centers, ultimately lowering infrastructure costs and facilitating reuse and recycling of treated wastewater. Established in 1998, Organica began as a traditional wastewater design-build company focused exclusively on the Hungarian market. During the first nine years of its life the company built over 75 municipal, commercial, and industrial WWTPs using a variety of different technologies, while continually investing into R&D to futher develop its own IFAS-type solution for biological wastewater treatment. In 2007 Organica sold it's design-build business to focus exclusively on the commercialization of its own biological wastewater treatment solution on a global basis. Today, Organica is an international company operating on three different continents, and the world leader in Fixed-Bed Biofilm Activated Sludge (FBAS) technology,with more than 25 operating references all over the world, and nearly a dozen additional Organica-powered WWTPs currently under construction.

Techno Venture Management is a venture capital and private equity firm focused on healthcare industry.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, Germany, United Kingdom

Portfolio highlights

Streaming21 — Checkout the full domain details of Streaming21.com. Click Buy Now to instantly start the transaction or Make an offer to the seller!
Revolt Technology — News & Informations
Helomics — Helomics® is a comprehensive personalized healthcare company, bringing the next generation of diagnostics to the oncology field. Helomics is dedicated to improving patient outcomes by providing a personalized comprehensive tumor profile utilizing a proprietary set of laboratory platforms that leverage both tissue-based live and fixed cellular basedanalysis allowing physicians to characterize malignant tumors on a personalized basis. Helomics’ novel molecular and cellular markers and bioinformatics services support treatment decisions by providing vital information based on the specific biological processes of each individual’s cancer.

MCI Capital is a leading Digital Private Equity investor in CEE, based in Warsaw, Poland. MCI Capital seeks to invest in digital disruption, transformation and infrastructure within EU, with focus on CEE. Preferred sectors are SaaS, E-commerce, Marketplace, Fintech, Insurtech, Foodtech, Traveltech and Digital Infrastructure. MCI typically investsEUR 25-100 M in a single project, either in Buyout or Expansion stage. Historically, MCI Capital has also been involved in funds dedicated to Private Debt, Growth and Venture Capital areas – these funds do not conduct any new investments, instead they focus on building the value of assets and de-investing.MCI Capital is managed by the executive management team. The company is listed on the Warsaw Stock Exchange since February 2001 and is also a member of the Polish Private Equity Association.

Investment focus

E-Commerce, Software, Mobile
Series A, Funding Round, Seed
Poland, Germany, United Kingdom

Portfolio highlights

IdoSell —
Gett — Gett is a technology platform focused on corporate Ground Transportation Management (GTM), where spend is estimated to exceed $100 billion globally. https://gett.com/why We are the GTM category leader, serving over a quarter of the Fortune 500 companies.Gett’s cloud-based software organizes thousands of transportation providers(corporate fleet, ride-hailing, taxi, and limos) into one single platform. The technology helps save businesses time and money by managing all their ground transportation spend, and optimizes the entire employee experience from booking and riding to invoicing and analytics.We are building the first ground transportation grid available to customers worldwide, similar to telephony and internet grids, with aspirations to become the standard in corporate ground transportation, just as Zoom became the standard in corporate communication.Founded in 2010 and headquartered in London, Gett has raised more than $750M in funding to date, including more than $300M from the Volkswagen Group. They employ over 800 employees globally.
ANSWEAR.com —

HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.

Investment focus

Biotechnology, Medical, Health Care
Series B, Funding Round, Series C
United States, Germany, Switzerland

Portfolio highlights

Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
Neuron23 — Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
Mineralys Therapeutics — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company founded by Catalys Pacific committed to developing best-in-class, novel therapy for the treatment of hypertension. The Company is driven to bring a targeted approach to the management of hypertension via the development of MLS-101. MLS-101, licensed from MitsubishiTanabe Pharma Corporation, is a highly selective and potent aldosterone synthase inhibitor that is being investigated for the treatment of hypertension.

Tet Ventures is one of the most active global food-tech investors. We work with and invest in technology that can improve the food system.

Investment focus

Food and Beverage, Biotechnology, E-Commerce
Seed, Pre-Seed, Funding Round
United States, Germany, United Kingdom

Portfolio highlights

Afterlife Ag — Eliminate organic waste from going into landfills. Peat upcycles your food waste into fresh, sustainable, and delicious mushrooms.
FORAY bioscience — FORAY bioscience is a biotechnology company that uses biomanufacturing techniques to produce wood products.
Prolific Machines — Prolific Machines harnesses light to produce everyday essentials more efficiently, from food and lifesaving drugs to novel biosolutions.

Valnon Holding is an investment firm that invest in early-stage companies.

Investment focus

Biotechnology, Chemical Engineering
Seed
Austria

Portfolio highlights

Lignovations — Lignovations develops high-performance ingredients from biomass. Accelerating the transition to a sustainable society.

GLS Ventures

Investment focus

Medical, Health Care, Biotechnology
Series B, Funding Round
Austria

Portfolio highlights

Nabriva Therapeutics — Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections.

The Austrian Federal Economic Chamber functions as the federal parent organization for the nine State Chambers and 110 trade associations for different industries within Austria's system of economy.

Investment focus

Software, Music, mHealth
Seed, Pre-Seed, Funding Round
Austria

Portfolio highlights

Music Traveler — Music Traveler is a rapidly growing aggregator and marketplace, bringing a highly fragmented B2B and B2BC environment to the sharing economy. Music Traveler centralises practice/rehearsal/performing spaces, equipment, and instruction for the performing arts – its mission is to promote the creation, appreciation and interest in music byy reducing barriers, facilitating new interactions.
The Apollinaire Group (TAG) — Intelligent supply chain management company.
SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.

Cutting-edge venture capital firm supporting the early-stage entrepreneurs building global businesses.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Pre-Seed
Germany, United States, United Kingdom

Portfolio highlights

iGent — iGent AI focus on integrating advanced AI capabilities into the software development process.
Artisan AI — Artisan is on a mission to build the first generation of AI employees, called Artisans, who can automate specific roles & workflows.
Beyond Presence — Human cloning company

Air Street Capital invests in AI-first companies.

Investment focus

Artificial Intelligence, Machine Learning, Biotechnology
Seed, Series A, Pre-Seed
United States, United Kingdom, Canada

Portfolio highlights

intenseye — Intenseye | Reduce workplace incidents and increase efficiency with the world's #1 safety management software.
Profluent Bio — We are fluent in the language of protein design.
Interloom Technologies — Interloom offers AI-driven process automation for enterprises to maximize organizational efficiency and accuracy.

Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.

Investment focus

Health Care, Biotechnology, Software
Seed, Series A, Pre-Seed
United States, Germany, United Kingdom

Portfolio highlights

Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
ExpressionEdits — Redefining the status quo of protein expression
Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.